• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    CRISPR Therapeutics AG - Common Shares (NQ:CRSP)

    55.51 +0.97 (+1.77%)
    Streaming Delayed Price Updated: 3:56 PM EDT, Jul 1, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about CRISPR Therapeutics AG - Common Shares

    < Previous 1 2 3 4 5 6 7 8 9
    ...
    36 37 Next >
    News headline image
    3 Mid-Cap Growth Stocks That Have Mammoth Long-Term Potential ↗
    These stocks have market caps of around $4 billion and $5 billion, and they could potentially double or triple in size in the long run. 
    Via The Motley Fool
    News headline image
    Agios Pharmaceuticals Plunges Over 50% as Sickle Cell Drug Delivers Mixed Phase 3 Results
    Boston, MA – November 19, 2025 – Agios Pharmaceuticals, Inc. (NASDAQ: AGIO) experienced a dramatic and immediate market backlash, with its stock plummeting over 51.00% following the announcement of... 
    Via MarketMinute
    News headline image
    Missed Out on Eli Lilly? 2 Healthcare Stocks With Big Catalysts on the Horizon. ↗
    These stocks both have advanced in the double-digits in recent months. 
    Via The Motley Fool
    Retail Bulls Call CRISPR ‘Criminally Undervalued’ After Gene-Editing Breakthrough Cuts Cholesterol By 70% ↗
    Via Stocktwits
    News headline image
    How Is The Market Feeling About CRISPR Therapeutics? ↗
     
    Via Benzinga
    News headline image
    1 Underrated Stock That Could Soar by 58%, According to Wall Street ↗
    This biotech has already made impressive contributions to medicine, and it could make more. But does that make it a buy? 
    Via The Motley Fool
    News headline image
    The Tech Tsunami: How Breakthroughs in AI, Quantum, and Green Energy Are Reshaping the Stock Market
    The global financial markets are in the midst of a profound transformation, driven by an accelerating wave of technological advancements. From the intricate algorithms of Artificial Intelligence to the... 
    Via MarketMinute
    Topics Artificial Intelligence ETFs Economy
    News headline image
    ARK Sold Almost 400,000 Shares of CRISPR Therapeutics. Is Cathie Wood Worried? ↗
    ARK Sold Almost 400,000 Shares of CRISPR Therapeutics. Is Cathie Wood Worried? 
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    CRISPR Therapeutics' Investigational Gene Therapy Shows Promising Lipid-Lowering Effects In Early Trial ↗
    CRISPR Therapeutics' CTX310 trial shows strong, sustained lipid reductions and favorable safety, boosting confidence in its gene editing platform. 
    Via Benzinga
    News headline image
    Why Gene-Editing Giants Crispr And Intellia Just Surged ↗
    The companies are working on one-and-done treatments for diseases tied to genetic problems. 
    Via Investor's Business Daily
    Topics Death
    News headline image
    Intellia Therapeutics Crashes After A Patient In Its Pivotal Study Dies ↗
    The company remains confident in its other gene-editing product, which would treat a swelling disorder. 
    Via Investor's Business Daily
    Topics Death
    News headline image
    AI Unlocks Gene-Editing Revolution: $2 Million Grant Propels Disease Cures
    A groundbreaking $2 million grant from the National Institutes of Health (NIH) is set to dramatically accelerate advancements in gene-editing technology, with artificial intelligence (AI) emerging as... 
    Via TokenRing AI
    Topics Artificial Intelligence Climate Change Intellectual Property
    News headline image
    Cathie Wood Goes All-In On Peter Thiel's Crypto Play Bullish With Back-To-Back Million-Dollar Buys ↗
    Cathie Wood-led Ark Invest purchased shares in Bullish, a crypto exchange backed by Peter Thiel, through three of its funds. Other key trades were also made, including buying shares in CRISPR and Beam... 
    Via Benzinga
    News headline image
    AI Unleashes a New Era in Cell and Gene Therapy: A Quarter Century Update Reveals Transformative Potential
    The burgeoning fields of cell and gene therapy (CGT) are on the cusp of a profound revolution, driven by the relentless advancements in artificial intelligence. This transformative impact was a central... 
    Via TokenRing AI
    Topics Artificial Intelligence
    News headline image
    Prediction: 2 Stocks That Will Be Worth More Than SoundHound AI 2 Years From Now ↗
    It is a smart strategy to diversify your portfolio by investing in high-quality companies built on proven technologies. 
    Via The Motley Fool
    Topics Artificial Intelligence
    News headline image
    Intellia Freezes Key Trial After Serious Liver Event, Stock Tumbles ↗
    Intellia Therapeutics (NASDAQ: NTLA) paused their Phase 3 MAGNITUDE and MAGNITUDE-2 trials after a serious liver-related adverse event. 
    Via Benzinga
    News headline image
    2 Soaring Cathie Wood Stocks to Buy and Hold ↗
    These companies' market-beating fuel hasn't run out yet. 
    Via The Motley Fool
    News headline image
    New to Growth Stocks? Here's 1 Every Investor Should Have on Their Radar. ↗
    CRISPR Therapeutics is a promising mid-cap biotech stock with an approved product in its portfolio. 
    Via The Motley Fool
    News headline image
    3 Monster Stocks to Hold for the Next 10 Years ↗
    Attempting to cash in on what's likely to be a relatively short-lived mania isn't a good idea for most investors most of the time. Every now and then, though, the right opportunity comes along. 
    Via The Motley Fool
    News headline image
    4 Healthcare Stocks to Buy Now ↗
    As investors crowd into AI names at record highs, these three healthcare stocks offer more compelling valuations. 
    Via The Motley Fool
    Topics Artificial Intelligence
    News headline image
    10 Health Care Stocks Whale Activity In Today's Session ↗
     
    Via Benzinga
    News headline image
    Healthcare Stocks Are Rising: Here Are 2 With Even More Upside Ahead ↗
    These biotechs could finally come into their own by the end of the decade. 
    Via The Motley Fool
    Topics Government World Trade
    News headline image
    10 Health Care Stocks Whale Activity In Today's Session ↗
     
    Via Benzinga
    News headline image
    Navigating the Future: Unlocking Investment Opportunities in High-Growth Sectors
    As of October 2025, the global financial markets are undergoing a profound transformation, driven by an accelerating wave of technological innovation and a pressing global imperative for... 
    Via MarketMinute
    Topics Artificial Intelligence Climate Change Economy
    News headline image
    3 Growth Stocks That Could Be 10-Baggers in 10 Years ↗
    Air taxis, quantum computing, and gene editing are all promising technologies to invest in for the long haul. 
    Via The Motley Fool
    News headline image
    Got $200? 2 Healthcare Stocks to Buy and Hold Forever ↗
    These stocks could see growth take off over the next few years. 
    Via The Motley Fool
    News headline image
    Could This Beaten-Down Stock Help You Become a Millionaire? ↗
    The company would need to maintain the strong momentum it's had this year for a long time. 
    Via The Motley Fool
    Topics ETFs
    News headline image
    The Pharmaceutical Revolution: AI, Gene Therapies, and Obesity Drugs Reshape a Trillion-Dollar Market
    The global pharmaceutical sector stands at the precipice of a monumental transformation, driven by an unprecedented convergence of scientific breakthroughs, technological innovation, and evolving... 
    Via MarketMinute
    Topics Artificial Intelligence Economy Intellectual Property
    News headline image
    My Top Biotech Stock Picks And Portfolio Strategy For The Next 3-10 Years ↗
    Forecasts in biotech market indicate that by 2030, gene therapy will become more accessible, potentially generating hundreds of billions dollars in revenue. 
    Via Benzinga
    News headline image
    Global Cell Therapy Market Size Expected to Reach $44 Billion as Demand for Regenerative Medicine Rises
    EQNX::TICKER_START (OTCQB:AVAI),(NASDAQ:TEM),(NASDAQ:CRSP),(NASDAQ:BNTX),(NYSE:BMY) EQNX::TICKER_END 
    Via FinancialNewsMedia
    Topics Artificial Intelligence
    < Previous 1 2 3 4 5 6 7 8 9
    ...
    36 37 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.